Property | Value |
?:abstract
|
-
Kanjanapan Y, Yip D Considerations for cancer immunotherapy during the COVID-19 pandemic Med J Aust 2020;213: 390-392 https://doi org/10 5694/mja2 50805 In this Perspective, on page 391, the sentence “Current guidelines recommend ICI monotherapy to be delivered at increased dosing intervals, such as nivolumab four times per week and pembrolizumab six times per week” is incorrect It should read: “Current guidelines recommend ICI monotherapy to be delivered at increased dosing intervals, such as nivolumab every four weeks and pembrolizumab every six weeks”
-
This article corrects the following: COVID‐19 lessons can help limit future legal liability Claudine McCarthy Volume 20, Issue 12 Campus Legal Advisor Pages: 4-5 First Published online: July 14, 2020
-
[This corrects the article DOI: 10.1016/j.cjco.2020.09.016.].
-
[This corrects the article DOI: 10.1016/j.dadm.2019.03.006.].
-
[This corrects the article DOI: 10.1016/j.dadm.2019.05.002.].
-
[This corrects the article DOI: 10.5152/ejbh.2020.240320.].
-
[This corrects the article doi: 10.1590/0100-6991e-20202458].
|
?:creator
|
|
?:journal
|
-
Alzheimers_Dement_(Amst)
-
Am_J_Nephrol
-
Am_J_Trop_Med_Hyg
-
Arthritis_Care_Res_(Hoboken)
-
Balkan_Med_J
-
Campus_Legal_Advisor
-
City_&_Society
-
Ethics_Hum_Res
-
Eur_J_Breast_Health
-
Hastings_Center_Report
-
Heart_Fail_Clin
-
J._foot_ankle_surg
-
J._heart_lung_transplant
-
J_Heart_Lung_Transplant
-
Med_J_Aust
-
Medicine_(Baltimore)
-
Rev_Col_Bras_Cir
-
Transplant_Proc
-
Urol_Int
|
?:license
|
|
?:publication_isRelatedTo_Disease
|
|
?:source
|
|
?:title
|
|
?:type
|
|
?:who_covidence_id
|
-
#1004230
-
#1049762
-
#1076827
-
#32605768
-
#32633624
-
#32647742
-
#32647743
-
#32726516
-
#32888643
-
#32937034
-
#33263655
-
#699520
-
#725926
-
#726277
-
#736799
-
#803682
-
#813026
-
#859722
-
#865480
-
#882569
-
#947873
-
#951175
-
#951717
-
#953421
-
#957972
-
#958337
-
#993925
|
?:year
|
|